Macroaxis: Personalized Investing
Simple Personalized Investing

SXC POW BCE IGM Stores Computers Exotic Commodities 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Processing. Please wait...

Zoommed Book Value Per Share

 
 Companies |  Insiders  | Dashboard  
     

Book Value Per Share breakdown for Zoommed

Book Value per Share (B/S) is can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing effects of liabilities. In other words a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of liquidation.

Zoommed

Book Value per Share

=

Common Equity

Average Shares

=
0.01 times
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as good will, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Compare Zoommed to competition

Zoommed Book Value Per Share Assessment

In accordance with recently published financial statements the book value per share of Zoommed Inc is about 0.01 times. This is 99.89% lower than that of Technology sector, and 99.77% lower than that of Healthcare Information Services industry, The Book Value Per Share for all stocks is 99.92% higher than the company.

Filter other Stocks by Book Value Per Share

Select Book Value Per Share Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  

Book Value Per Share Comparison

Zoommed is currently under evaluation in book value per share category among related companies.
Follow Zoommed Book Value Per Share with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Zoommed to your reader
 
    
ZMD Canada TSXV #B09KWD7CA
Zoommed Inc
Benchmark S&P 500
Currency: CAD - Canadian Dollar
Traded on TSX Venture Exchange
    
    

Other Zoommed Fundamentals

Return On Equity(128.05) %
Return On Asset(12.38) %
Profit Margin(40.85) %
Operating Margin(25.19) %
Current Valuation6.07 M
Shares Outstanding130.47 M
Price to Book8.00 times
Price to Sales1.42 times
Revenue3.67 M
EBITDA(400.44 K)
Net Income(1.5 M)
Cash and Equivalents532.89 K
Cash per Share0.01 times
Total Debt1.39 M
Debt to Equity2.09 times
Current Ratio0.25 times
Book Value Per Share0.01 times
Cash Flow from Operations552.55 K
One Year High0.05
One Year Low0.02
Number of Employees40
Market Capitalization5.22 M
Z Score1.8
Probability Of Bankruptcy39.38 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium